Table 1.
Study Participant Characteristics
| Characteristic | n (%) or mean (SD) |
|---|---|
| Age, mean (SD) | 33 years (4.6) |
| Months from delivery when interviewed, mean (range) | 10.1 months (3-33.1) |
| Race | |
| American Indian/Alaska Native | 1 (8.1%) |
| Black or African American | 3 (11.5%) |
| Mixed Race | 3 (11.5%) |
| White or Caucasian | 19 (73.1%) |
| Ethnicity | |
| Hispanic or Latina | 5 (19.2%) |
| Non-Hispanic or Latina | 21 (80.8%) |
| Sexual orientation | |
| Heterosexual | 24 (92.3%) |
| Lesbian/Bisexual | 2 (7.7%) |
| Relationship status | |
| Dating/Partnered | 5 (19.2%) |
| Single | 14 (53.8%) |
| Living with Partner | 7 (26.9%) |
| Married | 3 (11.5%) |
| Highest educational attainment | |
| Less than high school | 6 (23.1%) |
| High school/equivalent | 10 (38.5%) |
| Some college | 8 (30.8%) |
| College graduate/higher | 1 (3.8%) |
| Unknown | 1 (3.8%) |
| Living situation | |
| Residential treatment program/ sober house | 5 (19.2%) |
| Room, apartment, house that I own or rent | 13 (50.0%) |
| Shelter | 1 (4.0%) |
| Transitional Stabilization Services | 1 (3.8%) |
| With family or friends | 4 (15.4%) |
| Unknown | 1 (3.8%) |
| Age of first use of non-prescribed substances, Mean (SD) | 14 (5.1yrs) |
| Age of first use of opioids | 18.2 (5.7yrs) |
| History of injection drug use | 22 (84.6%) |
| Previously OUD treatment trials | |
| Methadone | 20 (76.9%) |
| Buprenorphine (Suboxone, Subutex) | 24 (92.3%) |
| Injectable buprenorphine | 4 (15.4%) |
| Naltrexone (oral) | 6 (23.1%) |
| Injectable naltrexone (Vivitrol) | 6 (23.1%) |
| MOUD at beginning of pregnancy | |
| Buprenorphine (Suboxone, Subutex) | 18 (69.2%) |
| Methadone | 7 (26.9%) |
| None | 1 (3.9%) |
| Current MOUD | |
| Buprenorphine (Suboxone, Subutex) | 12 (46.2) |
| Injectable buprenorphine | 2 (7.7%) |
| Methadone | 9 (34.6%) |
| None | 3 (11.5%) |